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SUMMARY
Diverse aspects of host-pathogen interactions have been studied using non-mammalian hosts
such as Dictyostelium discoideum, Caenorhabditis elegans, Drosophila melanogaster and
Danio rerio for more than 20 years. Over the last two years, the use of these model hosts to
dissect bacterial virulence mechanisms has been expanded to include the important human
pathogens Vibrio cholerae and Yersinia pestis. Innovative approaches using these alternative
hosts have also been developed, allowing new antimicrobials to be isolated through screening
large libraries of compounds in a C. elegans-Staphylococcus aureus infection model.  Host
proteins needed by Mycobacterium and Listeria during their invasion and intracellular growth
have been uncovered by high-throughput dsRNA screens in a Drosophila cell culture system,
while immune evasion mechanisms deployed by Pseudomonas aeruginosa during its
infection of flies have been identified. Together, these reports further illustrate the potential
and relevance of these non-mammalian hosts for modelling diverse aspects of bacterial
infection in mammals.
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2INTRODUCTION
The use of mammalian models to identify and understand virulence factors of human
pathogens is indispensable. Alternative models, such as the amoeba Dictyostelium
discoideum, the nematode Caenorhabditis elegans, the insect Drosophila melanogaster and
the fish Danio rerio are, however, complementary systems for such studies [1-5]. This is
possible because many human pathogens are of low species specificity and can infect hosts
ranging from insects and nematodes to fish, as well as other mammals. They rely on universal
virulence factors that are involved in the infection process regardless of the host. These can be
identified and characterised using genetically tractable and inexpensive non-mammalian
models. In addition, the molecular and genetic tools developed with these simple organisms
combined with their well-studied cellular biology and/or immunology allow one to decipher
the complex interactions between host and pathogen.
The four organisms listed above have in common many characteristics, such as ease of culture
and full sequenced genomes, that make them very useful as model hosts [1]. These alternative
hosts are being used for approaches as diverse as testing the virulence of chosen pathogen
mutants [6,*7], screening large banks of pathogen mutants for those with attenuated virulence
[8, *9, *10] or dissecting the host mechanisms involved in pathogen invasion and intracellular
replication [**11, *12, *13].
In addition, they have unique features relevant to the study of specific aspects of host-
pathogen interactions. The amoeba D. discoideum is a professional phagocyte that can be used
to decipher the molecular basis of phagocytosis and phagosome maturation [4]. Additionally,
it can give insights into how certain intracellular bacterial pathogens survive in the
phagolysosome [14]. The fly D. melanogaster possesses a very well-studied innate immunity
[15] that has contributed to the understanding of immune mechanisms in mammals. More
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immune system [*16, 17, **18]. Finally, genetic screens for bacterial virulence genes in a
vertebrate with a fully developed immune system [19] are possible with the fish D. rerio. This
review focuses on recent work with the alternative model hosts D. discoideum, C. elegans,
D. melanogaster and D. rerio in these new investigative paradigms.
New infections modelled with alternative hosts.
An increasing number of human bacterial pathogens are being tested in non-mammalian hosts
in order to study conveniently their virulence. In addition to established models such as
Pseudomonas aeruginosa [20,21], Salmonella typhimurium [22-24] or Serratia marcescens
[25,26], several pathogens including Listeria monocytogenes [27,28], Yersinia pestis (see
below) and Vibrio cholerae, the causal agent of cholera, have recently been added to the list
of micro-organisms able to cause lethal infection of the nematode and the fly.
In humans, expression of Cholera toxin (CT) by V. cholerae provokes a rise in cAMP in the
intestinal epithelium, the opening of ion channels and consequently loss of water into the
intestinal lumen. In mice, this secretory diarrhea can be successfully treated with the channel
blocker clotrimazole. It has now been reported that oral V. cholerae infection of the fruit fly
leads to the death of the animals in a manner somewhat similar to that observed in humans,
including rapid weight loss [*7]. CT is required for full virulence in the fly model and,
remarkably, flies with loss-of-function mutations in genes encoding homologues of the known
targets of CT resist infection. Furthermore, clotrimazole can help cure flies infected with V.
cholerae [*7].
During the lethal colonization of the C. elegans intestine by V. cholerae, on the other hand,
CT does not appear to play an important role [6]. But, using a reverse genetic approach,
Vaitkevicius and colleagues demonstrated that the quorum sensing regulated protease PrtV is
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important for V. cholerae in its natural niche [29] for its resistance to the marine plankton that
graze on it. Finally, they measured an increased IL-8 secretion in human epithelial intestinal
cells exposed to a V. cholerae prtV deletion mutant, compared to the parental strain,
suggesting a role for this protease in modulating (directly or indirectly) the host response in
vertebrates [6].
Together, these reports illustrate to what extent nematode and fly can be relevant for the study
of the causative agent of cholera. Importantly, the work by Blow and colleagues offers the
perspective of using Drosophila to screen for chemicals that inhibit CT in vivo, following a
precedent set by the Ausubel lab using C. elegans [**30].
In vivo screens for new antimicrobials
The massive use of antibiotics combined with the high adaptation capacity of bacteria has
created the public-health problem of human pathogens resistant to multiple antibiotics.
Therefore, there is a real need for new antibiotic molecules. Moy and colleagues cleverly used
an infection system involving a C. elegans immunocompromised mutant and Enterococcus
faecalis [**30] to screen for synthetic (6,000) and natural (>1,000) molecules that promoted
host survival (FIGURE 1). This in vivo screen not only permitted the identification of 8
molecules affecting bacterial growth in vitro (MIC < 35 µg/ml), but also of 8 other products
either impairing pathogen virulence or boosting host innate immunity in the absence of
significant in vitro activity (MIC > 125 µg/ml) [**30]. Even though the efficiency and
toxicity of the identified molecules does need to be tested in mammals, this system represents
a very promising screening platform to identify in vivo new antibacterial molecules. A similar
system involving flies to identify antifungal drugs is also being developed [31,32].
Random screens for the identification of bacterial virulence genes
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mutant libraries of Klebsiella pneumoniae, Y. pestis, and Streptococcus iniae, respectively,
have further strengthened the relevance of these simple hosts.
K. pneumoniae is an important human pathogen that, as its name suggests, causes pneumonia.
Its interaction with alveolar macrophages can be modelled using D. discoideum as a surrogate
phagocyte. D. discoideum is normally able to feed on wild-type Klebsiella. Benghezal and
colleagues elegantly combined the genetics of D. discoideum and the genetics of K .
pneumoniae. They first identified a new gene (phg1) [33] rendering the amoeba especially
susceptible to infection and unable to grow on Klebsiella. Then, they isolated Klebsiella
mutants that supported the growth of the phg1 mutant amoeba [*10]. Among the mutated
bacterial genes were several required for LPS and amino-acid biosynthesis. They tested
several of the isolated bacterial mutants in a mouse pneumonia model and found an
attenuation of virulence [*10].
The genetic manipulation of both host and pathogen allowed them to create a 2D virulence
array showing that distinct groups of host genes are necessary to resist infection by various
bacterial pathogens and mutants (FIGURE 2). They were also able to demonstrate
conservation of both virulence factors and defence genes since Drosophila phg1 mutants are
more susceptible to K. pneumoniae infection [*10].
Y. pestis, the causative agent of plague, can form a biofilm that is important for its
dissemination via its vector, the flea. A Y. pestis biofilm can also accumulate on the head of
C. elegans, and this is clearly a more accessible model to study biofilm function than looking
in the gut of the flea [34]. But as biofilm formation is only one aspect of Y. pestis
pathogenicity, Styer and colleagues developed a nematode-based infection system to identify
Y. pestis virulence genes not related to biofilm formation [*9]. They showed that a biofilm-
deficient mutant of Y. pestis colonises the intestine of C. elegans and provokes an early death.
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virulence in the worm. Remarkably, despite the differences between nematodes and
mammals, they identified two genes whose products are necessary for induction of mouse
death in an intranasal mouse model of Y. pestis pathogenesis, genes that had previously not
been implicated in Y. pestis virulence [*9].
S. iniae is a bacterial pathogen able to infect fish and humans. In order to analyze the
interaction between streptococcal pathogens and their natural hosts, Miller and colleagues
created a bank of bacterial mutants and screened it using zebrafish [8]. They wished to
identify bacterial mutants specifically deficient in their capacity to disseminate in the brain.
To facilitate the screening process, they used a Signature-Tagged Mutagenesis strategy [35]
that permitted the analysis of fish co-infected by a pool of 12 distinct mutant strains. Doing
so, they screened 1,128 signature-tagged transposon bacterial mutants and determined which
bacterial mutants were not present in brain extracts from infected fish. Interestingly, 7 out of
the 41 bacterial mutants isolated had transposon insertions in genes potentially coding for
surface polysaccharides, major components of the capsule. Finally, using the bacterial
mutants they isolated, they showed in a human whole blood assay for phagocytosis that S.
iniae’s capsule is involved in invasion and survival in human macrophages [8].
These three studies further validate the use of non-mammalian hosts for large-scale screens to
identify bacterial virulence genes relevant to infection in mammals. Moreover, the genetic
manipulation of the host as exemplified by the work of Benghezal et al., expands the range of
models available for this kind of screening approach, in a manner reminiscent of the directed
modification of mice, via trangenesis [36] or the creation of human-mouse chimeras [37], but
without any of the ethical concerns.
Identification of host molecules required for pathogenesis and how the pathogen evades
the immune system.
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such as those coding for interleukins or Toll-like receptors (TLRs). This is especially the case
for intracellular bacterial pathogens that have to enter the cell and avoid being degraded in
phagolysosomes. Therefore, intracellular bacteria have developed many ways to hijack the
endocytic or phagocytic routes [38,39]. Macrophages are often confronted by intracellular
pathogens as they are professional phagocytes. Three recent studies used the Drosophila S2
macrophage–like cell line to perform large scale RNAi screens to identify host factors
required for entry and survival of intracellular bacterial pathogens.
The first two analyses combined automated microscopy with the use of GFP-tagged
Mycobacterium fortuitum [*13] or Listeria monocytogenes [*12] to screen a bank containing
21,300 dsRNAs (targeting >95% of annotated Drosophila genes in a redundant fashion). They
showed that factors involved in vesicle trafficking and actin cytoskeleton organization are
necessary for internalization and intracellular survival of these two pathogens. Moreover, they
identified a Drosophila homologue of the scavenger receptor CD36 as being crucial for L.
monocytogenes and M. fortuitum entry into the S2 cells, while being dispensable for
phagocytosis in general [*12,*13]. Based on these observations, the study was extended to
mammalian cells and new roles in bacteria uptake described for members of the CD36 family.
This work also highlighted a role for autophagy in the control of L. monocytogenes infection
[*12].
In contrast to these two studies that used automated microscopy, a third study was performed
manually [**11].  In this painstaking project, interest was focused especially on the
interaction between the L. monocytogenes toxin listeriolysin O (LLO) and host factors that
allow the bacteria to escape from the phagosome. The authors combined RNAi against the
host with bacterial mutants for LLO. In a first set of experiments, they used an LLO-deficient
bacterial strain and screened for dsRNAs that restored the capacity of these mutants to escape
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pathways targeted by LLO. In a second set of experiments, they used a bacterial mutant
producing a LLO toxin lacking a PEST sequence (and thus with a longer half-life). They
screened for dsRNAs that rendered S2 cells more susceptible to this stable toxin to determine
which host enzymes control LLO toxicity. Based on their results, they propose a model in
which the pore-forming LLO inserts into the membrane of the L. monocytogenes-containing
phagosome, thus impairing its acidification and maturation. Concerning the host’s control of
LLO toxicity, their screen identified SPT, an enzyme necessary for sphingolipid metabolism,
as a key factor for host resistance [**11].
The experimental systems described in these three reports can thus be used to shed light on
the complex interactions between the host and an intracellular pathogen that are both fighting
for their survival. But just as is the case for any model system, the results come with a number
of caveats. It is well known that a dsRNA can interfere with off-target genes and so generate
false positive results [40]. And conversely, important genes can be missed if they are not
expressed in or on S2 cells, as is indeed the case for some receptors involved in phagocytosis
(Istvan Ando and Dan Hultmark, personal communication). Nevertheless, in the long term, by
combining large-scale screens in the host and the pathogen, it will be possible to define a
host-pathogen interactome (Figure 2) [41].
Extracellular bacterial pathogens are usually not able to survive phagocytosis. Many,
however, have developed strategies to counteract the humoral arm of the host immune system.
A handful of recent articles have demonstrated that Pseudomonas infection of
D. melanogaster is a most suitable system to study the host immune response and to uncover
the strategies used by the pathogen to elude defence mechanisms. In one article, the role of
the Pseudomonas exotoxin ExoS was directly addressed by ectopic expression in the eye or
by ubiquitous expression of this bacterial protein in the fly [17]. The authors showed with
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ubiquitous ExoS expression impairs the phagocytic capacity of fly macrophages without
affecting anti-microbial peptide gene induction [17]. In a complementary study, Liehl and
colleagues used host and pathogen mutants to demonstrate that the Pseudomonas AprA
metalloprotease directly degrades fly antimicrobial peptides [**18]. This protease thereby acts
as a virulence factor by enhancing bacterial survival within the host body fluid. In addition to
these reports, Apidianakis and colleagues compared microarray results from flies infected by
virulent or avirulent P. aeruginosa strains [*16]. Strikingly, this analysis revealed an as yet
uncharacterised mechanism used by P. aeruginosa in the early phases of the infection to limit
Drosophila antimicrobial genes expression at the transcriptional level.
Together, these studies illustrate the potential use of genetically tractable non-mammalian
hosts, with characterized immune systems, to decipher the mechanisms pathogens employ to
evade the host immune system. As exemplified above, it is possible to have a global approach
and/or to address precisely the role of a specific bacterial protein.
CONCLUSIONS
Molecular and physiological conservation within different bacteria and across eukaryotic
species renders the study of host-pathogen interaction using non-mammalian models
especially attractive. Moreover, it is likely that many of the virulence mechanisms that
pathogens use during their infection of humans in fact evolved since they favour survival in
the natural ecological niche and so are best studied using their natural predators, such as
D. discoideum and C. elegans. After a period when these model systems were used in
essentially one-sided approaches (e.g. screening banks of bacterial mutants for virulence
genes or identifying the host targets of bacterial virulence factors), more and more studies are
now exploiting a combination of bacterial and host genetics to address the molecular basis of
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pathogenicity and defence. The future promises to reveal details of the intimate but deadly
dance between pathogen and host that has been going on since the birth of eukaryotes.
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FIGURES
Figure 1
Protocol used by Moy and colleagues [**30] to screen in vivo for new antimicrobial
compounds using an established C. elegans-E. faecalis infection system. After culture and
amplification of nematode numbers on growth plates (seeded with the Escherichia coli strain
OP50) synchronised populations of worms are transferred to infection plates, seeded with
E. faecalis strain MMH594. After 8 hours, worms are washed off the plates and
approximately 25 individuals added to each well of a 96-well microtitre plate and then
assayed for their survival.  Compounds or extracts that extended worm survival by 2- to 3-
fold were selected for further analyses. While this screen was carried out manually, the
availability of the Union Biometrica Biosort (http://www.unionbio.com/products/copas2.html)
allows automation of the different steps.
Figure 2
Hypothetical host-pathogen two dimensional array inspired by data from Benghezal et al.
[*10]. The ability of host mutants to resist (green) or to be killed (red) by different bacterial
strains and bacterial mutants is indicated. Gene names are arbitrary with hrg and pvf for Host
Resistance Gene and Pathogen Virulence Factor, respectively. Based on this matrix, it can be
speculated that hrg-1 encoded protein is specifically involved in a mechanism necessary for
host resistance to bacterial virulence factors encoded by pvfB and pvfC. The hrg-3-pvfD
interaction would correspond to the case described by Liehl and colleagues [**18] with hrg-3
and pvfD being the Drosophila Imd and Pseudomonas aprA genes, respectively. Finally,
HRG-2 and HRG-4 can be host proteins necessary for bacterial invasion by pathogen C and
pathogen B and C, respectively, corresponding to the observations described in the reports by
Philips et al. and Agaisse et al. [*12, *13].
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